Blennow K - Search Results

1

Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies.

Mattsson-Carlgren N, Collij LE, Stomrud E, Pichet Binette A, Ossenkoppele R, Smith R, Karlsson L, Lantero-Rodriguez J, Snellman A, Strandberg O, Palmqvist S, Ashton NJ, Blennow K, Janelidze S, Hansson O. Mattsson-Carlgren N, et al. Among authors: blennow k. JAMA Neurol. 2024 Jan 1;81(1):69-78. doi: 10.1001/jamaneurol.2023.4596. JAMA Neurol. 2024. PMID: 38048096

2

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.

Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, Gottfries CG, Blennow K. Skoog I, et al. Among authors: blennow k. Neurology. 1998 Apr;50(4):966-71. doi: 10.1212/wnl.50.4.966. Neurology. 1998. PMID: 9566380

3

CSF markers for incipient Alzheimer's disease.

Blennow K, Hampel H. Blennow K, et al. Lancet Neurol. 2003 Oct;2(10):605-13. doi: 10.1016/s1474-4422(03)00530-1. Lancet Neurol. 2003. PMID: 14505582 Review.

4

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Hansson O, et al. Among authors: blennow k. Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6. Lancet Neurol. 2006. PMID: 16488378

5

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.

Simonsen AH, McGuire J, Hansson O, Zetterberg H, Podust VN, Davies HA, Waldemar G, Minthon L, Blennow K. Simonsen AH, et al. Among authors: blennow k. Arch Neurol. 2007 Mar;64(3):366-70. doi: 10.1001/archneur.64.3.366. Arch Neurol. 2007. PMID: 17353378

6

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K. Hansson O, et al. Among authors: blennow k. Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19. Dement Geriatr Cogn Disord. 2007. PMID: 17374949

7

Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.

Andersson ME, Sjölander A, Andreasen N, Minthon L, Hansson O, Bogdanovic N, Jern C, Jood K, Wallin A, Blennow K, Zetterberg H. Andersson ME, et al. Among authors: blennow k. Int J Mol Med. 2007 Aug;20(2):233-9. Int J Mol Med. 2007. PMID: 17611642

8

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

Stomrud E, Hansson O, Blennow K, Minthon L, Londos E. Stomrud E, et al. Among authors: blennow k. Dement Geriatr Cogn Disord. 2007;24(2):118-24. doi: 10.1159/000105017. Epub 2007 Jul 2. Dement Geriatr Cogn Disord. 2007. PMID: 17622715

9

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.

Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S. Hansson O, et al. Among authors: blennow k. Neurobiol Aging. 2009 Feb;30(2):165-73. doi: 10.1016/j.neurobiolaging.2007.06.009. Epub 2007 Jul 23. Neurobiol Aging. 2009. PMID: 17646035

10

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

Nielsen HM, Minthon L, Londos E, Blennow K, Miranda E, Perez J, Crowther DC, Lomas DA, Janciauskiene SM. Nielsen HM, et al. Among authors: blennow k. Neurology. 2007 Oct 16;69(16):1569-79. doi: 10.1212/01.wnl.0000271077.82508.a0. Epub 2007 Aug 29. Neurology. 2007. PMID: 17761554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,085 results

Search Page